US Stock MarketDetailed Quotes

OBIO Orchestra BioMed

Watchlist

5.300
+0.170+3.31%

Close May 22 16:00 ET

189.68MMarket Cap-3672P/E (TTM)

Orchestra BioMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

8.81%-13.11M

-57.49%-46.13M

-25.50%-10.97M

-41.70%-10.28M

-31.70%-10.49M

-170.12%-14.38M

-50.75%-29.29M

-8.74M

-7.26M

-7.97M

Net income from continuing operations

-23.06%-13.46M

-46.16%-49.12M

-31.47%-12.82M

-29.51%-13.32M

-53.51%-12.05M

-90.96%-10.94M

-46.03%-33.61M

---9.75M

---10.28M

---7.85M

Operating gains losses

----

-28.89%1.45M

409.29%1.15M

--0

102.76%294K

390.70%2.03M

--226K

---36K

--1.7M

Depreciation and amortization

4.23%74K

29.28%287K

2.86%72K

31.48%71K

46.00%73K

47.92%71K

22.65%222K

--70K

--54K

--50K

Other non cash items

39.42%-524K

-2,394.78%-3.08M

-15.53%-476K

-566.13%-867K

-601.16%-867K

-562.57%-865K

-38.25%134K

---412K

--186K

--173K

Change In working capital

58.47%-1.83M

-633.26%-3.31M

-223.40%-116K

115.09%613K

208.32%612K

-1,566.42%-4.42M

-117.37%-451K

--94K

--285K

---565K

-Change in receivables

60.00%32K

-112.00%-3K

---13K

631.25%85K

-9,400.00%-95K

-52.38%20K

-46.81%25K

--0

---16K

---1K

-Change in inventory

-29.55%31K

162.98%131K

-114.81%-8K

120.81%41K

153.47%54K

22.22%44K

-20,900.00%-208K

--54K

---197K

---101K

-Change in prepaid assets

95.99%-60K

-77.90%-781K

-997.22%-323K

2,550.00%265K

238.96%774K

-2,179.17%-1.5M

-1,613.79%-439K

--36K

--10K

---557K

-Change in payables and accrued expense

28.86%-1.28M

-95.67%145K

-53.40%493K

-58.82%668K

65.74%779K

-988.61%-1.8M

210.95%3.35M

--1.06M

--1.62M

--470K

-Change in other current liabilities

62.72%-63K

-117.24%-693K

-43.90%-177K

-18.24%-175K

-17.01%-172K

-270.71%-169K

---319K

---123K

---148K

---147K

-Change in other working capital

51.23%-497K

26.42%-2.11M

90.55%-88K

72.52%-271K

-217.90%-728K

-42.32%-1.02M

-298.47%-2.86M

---931K

---986K

---229K

Cash from discontinued investing activities

Operating cash flow

8.81%-13.11M

-57.49%-46.13M

-25.50%-10.97M

-41.70%-10.28M

-31.70%-10.49M

-170.12%-14.38M

-50.75%-29.29M

---8.74M

---7.26M

---7.97M

Investing cash flow

Cash flow from continuing investing activities

113.46%5.86M

116.67%10.69M

152.31%33.15M

5,879.91%12.95M

1,812.66%8.12M

-92,514.89%-43.53M

-592.60%-64.12M

-63.38M

-224K

-474K

Net PPE purchase and sale

77.14%-8K

86.80%-78K

105.56%3K

91.52%-19K

89.85%-27K

25.53%-35K

-115.69%-591K

---54K

---224K

---266K

Net investment purchase and sale

113.49%5.87M

116.94%10.77M

152.35%33.15M

--12.97M

4,015.87%8.15M

---43.49M

-578.00%-63.53M

---63.32M

--0

---208K

Cash from discontinued investing activities

Investing cash flow

113.46%5.86M

116.67%10.69M

152.31%33.15M

5,879.91%12.95M

1,812.66%8.12M

-92,514.89%-43.53M

-592.60%-64.12M

---63.38M

---224K

---474K

Financing cash flow

Cash flow from continuing financing activities

-99.97%18K

-55.24%46.22M

-110.14%-10.7M

100.16%4K

-99.90%86K

129.45%56.82M

2,685.95%103.26M

-5.09M

-2.5M

86.08M

Net issuance payments of debt

----

-405.26%-10.85M

---10.85M

--0

----

188.85%3.55M

--0

--4.55M

Net common stock issuance

----

--0

----

--109.83M

--0

----

Net preferred stock issuance

----

--82.55M

Proceeds from stock option exercised by employees

63.64%18K

33.68%254K

1,630.00%153K

0.00%4K

-11.34%86K

-88.89%11K

2,614.29%190K

---10K

--4K

--97K

Net other financing activities

----

650.64%56.81M

--0

3,626.38%56.81M

---10.32M

---5.08M

---2.5M

---1.12M

Cash from discontinued financing activities

Financing cash flow

-99.97%18K

-55.24%46.22M

-110.14%-10.7M

100.16%4K

-99.90%86K

129.45%56.82M

2,685.95%103.26M

---5.09M

---2.5M

--86.08M

Net cash flow

Beginning cash position

54.46%30.56M

99.07%19.78M

-80.33%19.08M

-84.66%16.41M

-36.26%18.7M

99.07%19.78M

-51.15%9.94M

--97M

--106.97M

--29.33M

Current changes in cash

-564.37%-7.24M

9.44%10.78M

114.87%11.48M

126.75%2.67M

-102.94%-2.29M

-105.62%-1.09M

194.63%9.85M

---77.21M

---9.98M

--77.64M

End cash Position

24.76%23.32M

54.46%30.56M

-80.33%19.08M

-84.66%16.41M

-36.26%18.7M

99.07%19.78M

--19.78M

--97M

--106.97M

Free cash flow

8.98%-13.12M

-54.64%-46.21M

-24.70%-10.97M

-37.71%-10.3M

-27.77%-10.52M

-168.40%-14.42M

-51.65%-29.88M

---8.8M

---7.48M

---8.23M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	8.81%-13.11M	-57.49%-46.13M	-25.50%-10.97M	-41.70%-10.28M	-31.70%-10.49M	-170.12%-14.38M	-50.75%-29.29M	-8.74M	-7.26M	-7.97M
Net income from continuing operations	-23.06%-13.46M	-46.16%-49.12M	-31.47%-12.82M	-29.51%-13.32M	-53.51%-12.05M	-90.96%-10.94M	-46.03%-33.61M	---9.75M	---10.28M	---7.85M
Operating gains losses	----	-28.89%1.45M	409.29%1.15M	--0	--0	102.76%294K	390.70%2.03M	--226K	---36K	--1.7M
Depreciation and amortization	4.23%74K	29.28%287K	2.86%72K	31.48%71K	46.00%73K	47.92%71K	22.65%222K	--70K	--54K	--50K
Other non cash items	39.42%-524K	-2,394.78%-3.08M	-15.53%-476K	-566.13%-867K	-601.16%-867K	-562.57%-865K	-38.25%134K	---412K	--186K	--173K
Change In working capital	58.47%-1.83M	-633.26%-3.31M	-223.40%-116K	115.09%613K	208.32%612K	-1,566.42%-4.42M	-117.37%-451K	--94K	--285K	---565K
-Change in receivables	60.00%32K	-112.00%-3K	---13K	631.25%85K	-9,400.00%-95K	-52.38%20K	-46.81%25K	--0	---16K	---1K
-Change in inventory	-29.55%31K	162.98%131K	-114.81%-8K	120.81%41K	153.47%54K	22.22%44K	-20,900.00%-208K	--54K	---197K	---101K
-Change in prepaid assets	95.99%-60K	-77.90%-781K	-997.22%-323K	2,550.00%265K	238.96%774K	-2,179.17%-1.5M	-1,613.79%-439K	--36K	--10K	---557K
-Change in payables and accrued expense	28.86%-1.28M	-95.67%145K	-53.40%493K	-58.82%668K	65.74%779K	-988.61%-1.8M	210.95%3.35M	--1.06M	--1.62M	--470K
-Change in other current liabilities	62.72%-63K	-117.24%-693K	-43.90%-177K	-18.24%-175K	-17.01%-172K	-270.71%-169K	---319K	---123K	---148K	---147K
-Change in other working capital	51.23%-497K	26.42%-2.11M	90.55%-88K	72.52%-271K	-217.90%-728K	-42.32%-1.02M	-298.47%-2.86M	---931K	---986K	---229K
Cash from discontinued investing activities
Operating cash flow	8.81%-13.11M	-57.49%-46.13M	-25.50%-10.97M	-41.70%-10.28M	-31.70%-10.49M	-170.12%-14.38M	-50.75%-29.29M	---8.74M	---7.26M	---7.97M
Investing cash flow
Cash flow from continuing investing activities	113.46%5.86M	116.67%10.69M	152.31%33.15M	5,879.91%12.95M	1,812.66%8.12M	-92,514.89%-43.53M	-592.60%-64.12M	-63.38M	-224K	-474K
Net PPE purchase and sale	77.14%-8K	86.80%-78K	105.56%3K	91.52%-19K	89.85%-27K	25.53%-35K	-115.69%-591K	---54K	---224K	---266K
Net investment purchase and sale	113.49%5.87M	116.94%10.77M	152.35%33.15M	--12.97M	4,015.87%8.15M	---43.49M	-578.00%-63.53M	---63.32M	--0	---208K
Cash from discontinued investing activities
Investing cash flow	113.46%5.86M	116.67%10.69M	152.31%33.15M	5,879.91%12.95M	1,812.66%8.12M	-92,514.89%-43.53M	-592.60%-64.12M	---63.38M	---224K	---474K
Financing cash flow
Cash flow from continuing financing activities	-99.97%18K	-55.24%46.22M	-110.14%-10.7M	100.16%4K	-99.90%86K	129.45%56.82M	2,685.95%103.26M	-5.09M	-2.5M	86.08M
Net issuance payments of debt	----	-405.26%-10.85M	---10.85M	--0	----	----	188.85%3.55M	--0	--0	--4.55M
Net common stock issuance	----	--0	--0	----	----	----	--109.83M	--0	----	----
Net preferred stock issuance	----	----	----	----	----	----	----	----	----	--82.55M
Proceeds from stock option exercised by employees	63.64%18K	33.68%254K	1,630.00%153K	0.00%4K	-11.34%86K	-88.89%11K	2,614.29%190K	---10K	--4K	--97K
Net other financing activities	----	650.64%56.81M	--0	--0	--0	3,626.38%56.81M	---10.32M	---5.08M	---2.5M	---1.12M
Cash from discontinued financing activities
Financing cash flow	-99.97%18K	-55.24%46.22M	-110.14%-10.7M	100.16%4K	-99.90%86K	129.45%56.82M	2,685.95%103.26M	---5.09M	---2.5M	--86.08M
Net cash flow
Beginning cash position	54.46%30.56M	99.07%19.78M	-80.33%19.08M	-84.66%16.41M	-36.26%18.7M	99.07%19.78M	-51.15%9.94M	--97M	--106.97M	--29.33M
Current changes in cash	-564.37%-7.24M	9.44%10.78M	114.87%11.48M	126.75%2.67M	-102.94%-2.29M	-105.62%-1.09M	194.63%9.85M	---77.21M	---9.98M	--77.64M
End cash Position	24.76%23.32M	54.46%30.56M	54.46%30.56M	-80.33%19.08M	-84.66%16.41M	-36.26%18.7M	99.07%19.78M	--19.78M	--97M	--106.97M
Free cash flow	8.98%-13.12M	-54.64%-46.21M	-24.70%-10.97M	-37.71%-10.3M	-27.77%-10.52M	-168.40%-14.42M	-51.65%-29.88M	---8.8M	---7.48M	---8.23M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall